Milam Katelyn E, Parikh Samir M
Center for Vascular Biology Research; Beth Israel Deaconess Medical Center and Harvard Medical School ; Boston, MA USA.
Center for Vascular Biology Research; Beth Israel Deaconess Medical Center and Harvard Medical School ; Boston, MA USA ; Division of Nephrology; Beth Israel Deaconess Medical Center and Harvard Medical School ; Boston, MA USA.
Tissue Barriers. 2015 Apr 3;3(1-2):e957508. doi: 10.4161/21688362.2014.957508. eCollection 2015.
The ability of small blood vessels to undergo rapid, reversible morphological changes is essential for the adaptive response to tissue injury or local infection. A canonical feature of this response is transient hyperpermeability. However, when leakiness is profound or persistent, adverse consequences accrue to the host, including organ dysfunction and shock. A growing body of literature identifies the Tie2 receptor, a transmembrane tyrosine kinase highly enriched in the endothelium, as an important regulator of vascular barrier function in health and in disease. The principal ligands of Tie2, Angiopoietins 1 and 2, exert opposite effects on this receptor in the context of inflammation. This review will focus on recent studies that have illuminated novel aspects of the exquisitely controlled Tie2 signaling axis while proposing unanswered questions and future directions for this field of study.
小血管进行快速、可逆形态变化的能力对于组织损伤或局部感染的适应性反应至关重要。这种反应的一个典型特征是短暂的高通透性。然而,当渗漏严重或持续时,会给宿主带来不良后果,包括器官功能障碍和休克。越来越多的文献表明,Tie2受体是一种在内皮细胞中高度富集的跨膜酪氨酸激酶,是健康和疾病状态下血管屏障功能的重要调节因子。Tie2的主要配体血管生成素1和2在炎症环境中对该受体发挥相反的作用。本综述将聚焦于近期的研究,这些研究揭示了精确调控的Tie2信号轴的新方面,同时提出了该研究领域尚未解决的问题和未来方向。